Edition:
Deutschland

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

85.48USD
6 Dec 2019
Change (% chg)

$0.24 (+0.28%)
Prev Close
$85.24
Open
$85.67
Day's High
$85.91
Day's Low
$85.39
Volume
1,086,662
Avg. Vol
1,458,980
52-wk High
$88.76
52-wk Low
$65.44

About

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded... (more)

Buy/Sell

Sell Hold Buy
1.61 Mean rating from 18 analysts

Overall

Beta: 1.57
Market Cap(Mil.): $95,559.38
Shares Outstanding(Mil.): 1,737.44
Dividend: 0.26
Yield (%): 1.93

Stents no better than drugs for many heart patients -U.S. study

CHICAGO, Nov 16 Many patients with severe but stable heart disease who routinely undergo invasive procedures to clear and prop open clogged arteries would do as well by just taking medications and making lifestyle changes, U.S. researchers reported on Saturday.

PRESS DIGEST - Wall Street Journal - Nov 14

Nov 14 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

Abbott CEO Miles White to step down next year

Abbott Laboratories longtime Chief Executive Officer Miles White will step down in favour of his chief of operations in March, handing over the reins after successfully reshaping the healthcare conglomerate in a series of transformative deals.

Abbott CEO Miles White to step down next year

Abbott Laboratories longtime Chief Executive Officer Miles White will step down in favor of his chief of operations in March, handing over the reins after successfully reshaping the healthcare conglomerate in a series of transformative deals.

UPDATE 2-Abbott CEO Miles White to step down next year

Nov 13 Abbott Laboratories longtime Chief Executive Officer Miles White will step down in favor of his chief of operations in March, handing over the reins after successfully reshaping the healthcare conglomerate in a series of transformative deals.

Abbott CEO Miles White to step down next year

Nov 13 Abbott Laboratories said on Wednesday Chief Executive Officer Miles White would step down next year and be replaced by Chief Operating Officer Robert Ford.

UPDATE 2-FDA classifies Abbott's blood pumping system recall as most serious

Nov 4 The U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories' CentriMag blood pumping system following the death of a patient, as Class 1 or the most serious type of recall.

FDA classifies Abbott's blood pumping system recall as most serious

Nov 4 The U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories' CentriMag blood pumping system, following the death of a patient, as Class 1 or the most serious type of recall.

Photo

Abbott revenue misses as heart devices eclipse diabetes gains

Abbott Laboratories fell just short of Wall Street estimates for quarterly revenue on Wednesday, as weakness in the medical device maker's cardiovascular business overshadowed strong performance in its fast-growing diabetes care unit.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.68%
Rohstoffe +0.93%
Industrie +0.59%
Konjunktur abhängige Waren & Dienstleistungen +0.56%
Konjunktur unabhängige Waren & Dienstleistungen +0.87%
Finanzindustrie +0.54%
Pharma +0.97%
Technologie +0.28%
Telekommunikation -0.03%

Nachrichten aus der Wirtschaft

Photo

Schweizer Börse legt zu - Swiss Re nach Spartenverkauf gesucht

Zürich Gute US-Konjunkturdaten haben der Schweizer Börse zum Wochenschluss Schub verliehen. Der SMI gewann rund ein Prozent auf 10.463 Punkte. Der stärkste Stellenaufbau in den USA seit zehn Monaten zeigte Händler zufolge, dass der US-Arbeitsmarkt in besserer Verfassung ist erwartet. Trotz des Schlussspurts verbuchte der Leitindex im Verlauf der gesamten Woche ein Minus von rund 0,3 Prozent.